3M CO Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
3M CO (MMM) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $148.87 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-02-03
- 3M CO share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $162.39.
- 3M CO share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $148.87, a 53.24% increase from fiscal 2024.
- 3M CO share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $97.15, a 16.87% decline from fiscal 2023.
- 3M CO share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $116.87, a 28.03% decline from fiscal 2022.
- 3M CO share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $162.39, a 7.23% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-12-31 | $148.87 10-K · filed 2026-02-03 | |||
| 2024-12-31 | $97.15 10-K · filed 2025-02-05 | |||
| 2023-12-31 | $116.87 10-K · filed 2024-02-07 | |||
| 2022-12-31 | $162.39 10-K · filed 2023-02-08 | |||
| 2022-09-30 | $162.39 10-Q · filed 2022-10-25 | |||
| 2022-06-30 | $162.39 10-Q · filed 2022-07-27 | |||
| 2022-03-31 | $162.39 10-Q · filed 2022-04-26 | |||
| 2021-12-31 | $175.04 10-K · filed 2023-02-08 | |||
| 2021-09-30 | $175.04 10-Q · filed 2021-10-26 | |||
| 2020-12-31 | $157.25 10-K · filed 2023-02-08 | |||
| 2019-12-31 | $200.80 8-K · filed 2022-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |